Vimarsana
Biggest News Aggregation in the World

Page 10 - Adjusted Diluted News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adjusted Diluted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adjusted Diluted Today - Breaking & Trending Today

Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook - Vimarsana News

Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook

Lamb Weston Holdings, Inc. (NYSE: LW) announced its results for the third quarter of fiscal 2024 and updated its full year earnings targets for fiscal 2024.

Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook - Vimarsana News

Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook

Third Quarter Fiscal 2024 Highlights GAAP and Non-GAAP results include a temporary, higher-than-expected impact from the transition to a new enterprise resource planning system in North America...

Acuity Brands Reports Fiscal 2024 Second-Quarter Results - Vimarsana News

Acuity Brands Reports Fiscal 2024 Second-Quarter Results

Solid Execution Continues Delivering Margin Expansion and EPS GrowthDelivered Net Sales of $906M, a 4% Decline Compared to the Prior YearGrew Operating Profit to $118M, up 6% Over the Prior Year;...

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results - Vimarsana News

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Total revenue of $18.3 million and diluted earnings per share of $0.20 Maintains full-year revenue guidance of $66 to $69 million and EPS guidance of $0.66 to $0.68 ...

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results - Vimarsana News

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter fiscal 2024, ended February 29, 2024....